Haque, A. et al. 2013. Efficacy, Safety and tolerability of the once-daily 10 cm² rivastigmine patch formulation in the patients with dementia (with probable Alzheimer’s disease). Bangladesh Journal of Neuroscience. 29, 1 (Jan. 2013), 5–14. DOI:https://doi.org/10.3329/bjn.v29i1.56165.